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Objective: This investigation assessed preferences for, and effects of, 5 days of twice daily 
superficial heat, cold, or contrast therapy applied with a commercially available system   permitting 
the circulation of water through a wrap-around garment, use of an electric heating pad, or rest 
for patients with level II–IV osteoarthritis (OA) of the knee.
Methods: We employed a within subject, randomized order design to study 34 patients   receiving 
each treatment in 1-week blocks. A knee injury and osteoarthritis outcome score (KOOS) 
questionnaire and visual analog pain scale was completed at baseline, and twice each week. 
Treatment preferences were assessed in the last week of the study.
Results: Treatment with the device set to warm was preferred by 48% of subjects. Near equal 
preferences were observed for cold (24%) and contrast (24%). Pain reduction and improve-
ments in KOOS subscale measures were demonstrated for each treatment but responses were 
(P , 0.05) greater with preferred treatments. Most patients preferred treatment with the water 
circulating garment system over a heating pad.
Conclusions: We recommend that when superficial heat or cold is considered in the management 
of knee OA that patients experiment to identify the intervention that offers them the greatest 
relief and that contrast is a treatment option.
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Osteoarthritis (OA) of the knee is a common and progressive condition. Michael et al1 
reported that 6% of adults suffer from clinically significant knee OA with the prevalence 
increasing with each decade of life. Lawrence et al2 provided a summary of population 
based studies which revealed estimates of symptomatic and   radiographically confirmed 
knee OA as high as 16.7%3 for those 45 years and older, with women more affected 
than men.2 OA results in pain and recurrent swelling and is associated with   progressive 
functional limitations and disability.2 Multiple treatment options are available for 
patients with OA of the knee including the use of superficial heat or cold,   transcutaneous 
electrical nerve stimulation (TENS), oral medications, injection of hyaluronic acid or 
a corticosteroid, or ultimately knee joint replacement surgery.4–6
Unfortunately, knee OA is a progressive disease and not all patients are good 
  candidates for all interventions. Moreover, there are risks and side effects associated 
with medications and surgery that are not associated with some remedies, such as 
superficial heat or cold applications.6,7 Furthermore, not all treatment options meet 
with the same results, supporting individualized patient management approaches. The 
benefits of   others such as injections of hyaluronic acid or a corticosteroid do not last 
indefinitely and must be repeated.8,9 The use of lower risk, lower cost   interventions that Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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are effective in helping patients manage chronic   conditions 
including knee OA, warrant further examination and   attention 
when discussing treatment options or recommending a plan 
of care.
The periodic application of superficial heat or cold 
is a   relatively safe and low cost treatment that can be 
  recommended in isolation or in combination with other treat-
ments for patients with knee OA.10 Contrast therapy involv-
ing intervals of heat and cold application within a treatment 
session offers yet another option in the management of many 
different musculoskeletal conditions, including knee OA. 
Few studies are available to demonstrate if either superficial 
heat, cold, or contrast therapies are of greater benefit.11
Despite limited understanding of the response to heat, 
cold, or contrast modalities in the management of knee OA, 
the application of superficial heat or cold is very common, 
often self-initiated, and is considered a component of a 
“first-line” intervention in the management of knee pain in 
older adults.4,12 Porcheret et al12 reported that of 201 older 
patients with knee pain surveyed, 84% reported applying 
superficial heat or cold, and most reported this treatment 
as a self-initiated intervention. Additionally, Cetin et al4 
reported that the use of superficial heat or cold in conjunction 
with diathermy, TENS or ultrasound led to varying levels 
of symptom relief and functional improvements in patients 
with knee OA.
Health care providers are often asked whether heat or cold 
is better, and how these modalities should be used outside of 
clinical settings for treatment of knee OA.11 Unfortunately, 
as previously noted, there are no clear answers or recom-
mendations for patients to follow, hence anecdotal recom-
mendations are often based on personal experiences, patient 
preferences, and previously established clinical training and 
education.10–15
Studying the response to thermal modalities is compli-
cated by the fact that it is not possible to blind subjects or 
providers to the intervention. Moreover, clinical observations 
show many patients have experiences with heat and cold 
applications and express preferences based on these experi-
ences. The first purpose of this Phase I study (subjects were 
randomized to order but not to a particular treatment with 
primary focus on treatment preference) was to investigate the 
preferences of patients with knee OA using a single device 
that is able to provide multiple treatment options with an 
identical method of application.
Other factors may also need to be considered in recom-
mending treatments. Impairments of the hand and loss of 
mobility in the lower extremities may impede an individual’s 
ability to self-apply superficial heat and cold around a 
  peripheral joint. For example, securing an ice pack can be 
difficult for some patients. Furthermore, wrapping an elec-
tric heating pad in place poses risk of burns, especially if 
peripheral sensation or circulation is compromised. Several 
commercially available warm and cold-water circulating 
units offer a means of surrounding a joint with a garment 
through which temperature controlled water circulates. These 
garments are wrapped around the joint and held in place with 
Velcro™ closures. These garments may offer a safer and 
more convenient means of applying cold or heat. The second 
purpose of this investigation was to assess the preferences 
of patients toward a given treatment option provided by a 
wrap-around system when compared to use of a standard 
electric heating pad.
A preferred treatment may or may not yield a better out-
come. The third purpose of this investigation was to assess 
self-reports of patients with level II or greater OA16 for pain, 
symptoms, function in daily living (FDL) and recreation, 
and quality of life (QOL), following 5 days of twice daily 
superficial heat, cold or contrast therapy applied with a wrap-
around water circulating device, twice daily use of a standard 
heating pad, or twice daily rest for 20 minutes.
Materials and methods
Thirty-six subjects, with Kellgren-Lawrence scale16 level II 
or greater OA, as diagnosed by their independent refer-
ring physician, were recruited to participate in a study that 
was approved by the University of Connecticut, Office of 
Research Compliance, for use of subjects in research. Each 
provided written informed consent to participate after the 
risks and benefits of the study were explained to them. Par-
ticipants were recruited through presentations and posted 
announcements within a university community and four (two 
rural and two urban) community senior centers, from June 
2008 to December 2009. Enrollment criteria were described 
and 36 subjects volunteered for the study. A small number 
(,10 individuals) contacted the investigators via telephone 
or in person at a senior center to review their suitability for 
enrollment but did not qualify, most commonly because their 
knee had not been examined radiographically.
Thirty-four community dwelling subjects, average age 
of 62 ± 14 years, median grade OA = III (23 women, 
64.87 ± 10.67 years and median grade OA = III, and 11 men, 
54.6 ± 19.91 years and median grade OA = III) completed 
the study; the distribution of severity by gender is reported 
in Table 1. Two subjects (one woman, one man) were lost 
due to non-study related medical complications (illness Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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precluding travel to weekly meetings and elective total hip 
arthrosplasty due to increasingly severe hip pain respec-
tively) during the course of the study. Neither of these two 
participants completed more than 2 weeks of treatment for 
the study. Any potential subject was excluded if they had 
received either hyaluronic acid or corticosteroid injections 
to either knee within the past 6 months, or had a history of 
an adverse reaction to cold application or diminished sensa-
tion to heat or cold in the area of the knee. Furthermore, all 
subjects were advised to not increase the use of nonsteroidal 
anti-inflammatory medication at any point in time during the 
study. All subjects were medically cleared for participation 
by a physician (personal physician or orthopedic surgeon) 
knowledgeable of the participant’s medical history, sever-
ity of symptoms from OA and current health status. The 
physician was asked to grade the severity of OA of the most 
involved knee on a form describing each level of the Kell-
gren-Lawrence scale.16 All subjects demonstrated the abil-
ity to self-apply the water-circulating device and complete 
the assigned treatments and questionnaires as instructed by 
members of the research team.
Subjects met with a member of the investigational team 
for an orientation session in a university laboratory room or 
a senior center where they regularly attended community 
activities. The study was described and questions addressed 
before asking for consent to participate. Once consent was 
obtained subjects were instructed in how to complete the knee 
injury and osteoarthritis outcome score (KOOS) self-report 
questionnaire and 10 cm visual pain scale. Details regard-
ing the KOOS instrument as well as the process of scoring 
responses can be found at http://www.koos.nu/. Subjects 
were then advised as to their first treatment assignment and 
instructed in the completion of that treatment. Prior to meet-
ing with any potential subjects, the order of treatments was 
balanced and randomized to eliminate any statistical order 
effects. Forty different treatment orders were randomly 
selected from the 120 possible order combinations, and were 
numbered consecutively. When subjects enrolled, they were 
assigned to the order from a random draw of numbers corre-
sponding to a treatment option. Subjects were not informed of 
treatment order, and would learn of their assigned treatment 
at the beginning of each week of the study.
Each participant completed five treatment protocols 
including cold, warm, and contrast (alternating cold and 
warm) with the water circulating system; superficial heat 
with an electric heating pad, or control (no treatment) of 1 
week (7 days) duration. The water-circulating device used for 
this study was the VitalWrap® portable thermal and compres-
sion system (VitalWear Inc., San Francisco, CA, USA). This 
commercially available device offers a convenient means of 
applying superficial cold, heat, and an option for contrast 
through a garment wrapped around the knee.
Each treatment protocol consisted of twice-a-day 
(morning and evening) application of one of the treatment 
options for 5 consecutive days, followed by 2 days of 
  nontreatment. Each of the twice daily treatments was applied 
for 20   minutes except for the contrast treatment, which 
consisted of 4   minutes of warm followed by 2 minutes of 
cold (the 4 minute by 2 minute cycle of heat, then cold, was 
repeated 3 times) and concluded with 4 minutes of warm, in 
a total session of 22 minutes. During the control week of the 
study, participants sat quietly for 20 minutes each day in a 
self-determined position of maximal comfort.
Subjects completed the KOOS self-report questionnaire 
and visual analog pain scale at baseline (at the beginning of 
the study, prior to any treatment application), and then twice 
on the 5th and 7th day of each treatment week. The KOOS was 
selected as the instrument of choice for measuring changes 
in the patients, since it is a validated exam for response to 
treatment in individuals with knee OA across a lifespan 
and regardless of level of activity.17 It is an easy-to-use, 
self-administered survey that provides for a comprehensive 
examination of five subscales (pain, symptoms, functions, 
sports and recreational activities, FDL, and QOL) that are of 
importance to function and independence for many individu-
als with knee OA.
Following the completion of all five of the treatment 
protocols, subjects completed a preference for treatment 
scale and were asked about any adverse events and changes 
in weekly medication. No subject reported an adverse event 
and there was no report of a change in any anti-inflammatory 
or analgesic medications for any week of the study. To assess 
treatment preference, subjects were asked to rank the treat-
ment options from most preferred through least preferred 
Table 1 Breakdown of gender and severity of osteoarthritis for all subjects (n = 34)
% of subject population that is
All subjects Level II OA: 26.4% Level III OA: 52.9% Level IV OA: 17.6% Level unknown
Men: 32% (n = 11) Male: n = 3 Male: n = 7 Male: n = 1 Male: n = 1
Women: 68% (n = 23) Female: n = 6 Female: n = 11 Female: n = 5Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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including the nontreatment control week. Subjects were 
also encouraged to provide comments on their preferences 
and experiences with each treatment option used during 
this study.
Statistical analyses
Prior to the initiation of the study, we calculated the N size 
power based on a change of 15% in median score of the 
visual pain scale, and determined that there would need to 
be a population of 30 subjects to obtain the desired power of 
0.80. Pain was selected for consideration since it is of pri-
mary concern and offered the best means of judging whether 
additional investigation might be warranted as a follow-up to 
learning more regarding treatment preference.
After each week of treatment, subject data collected were 
tabulated from the day 5 and 7 KOOS questionnaire subscales 
of pain, symptoms, sports and recreation activities, FDL, and 
QOL, and the visual analog pain for each treatment, along 
with baseline and control week scores. Additionally,   subject 
preferences were tabulated to identify subgroups of the 
sample. These data were used to investigate the relationships 
between treatment preference and changes in reported pain, 
and KOOS subscale responses.
Data were analyzed by a member of the research team who 
had no contact with subjects or the data collection process. 
Preference data were presented descriptively. Differences 
in treatment response were analyzed separately for each of 
the subscales of interest (as the KOOS was not developed to 
yield a composite score). Pain data from the visual analog 
scale were also analyzed separately. Responses to treatment 
for the day 5 measurements were assessed without regard to 
preference, and then by treatment of preference, via paired 
T-tests (P # 0.05), with Bonferroni correction. Effect sizes 
for treatment were determined in reference to day 5 control 
values (µactive – µcontrol)/(σactive and control) for active   treatments. As 
a follow-up, KOOS and visual analog pain data were also 
analyzed to identify differences between treatment days 5 
and 7 in each treatment option, via a within-subject repeated 
measure analysis of variance, (P # 0.05).
Results
As shown in Table 2, participants reported a range of   individual 
preferences for treatment setting. More participants preferred 
the warm treatment condition, but nearly one-half preferred 
either cold or the contrast treatment. Most (32 of 34) preferred 
treatment with the water-circulating device compared to the 
use of a standard heating pad or no treatment. Regardless of 
the preference, there were, on average, significant (P , 0.05) 
improvements in pain, symptoms, FDL and QOL KOOS 
subscale measures with the water circulating device treat-
ment options, (see Tables 3 and 4), when compared with 
baseline and control week measurements. Twice daily rest 
(control treatment) resulted in improvements over baseline 
measures, and therefore the control week data served as our 
means for comparison with all active treatment options. The 
extent of improvement in pain and symptoms was often more 
pronounced when subjects utilized their preferred treatment 
versus their nonpreferred treatment (Tables 3 and 4).
Data on the function, sport and recreational activities 
subscale were analyzed, as were data from the other sub-
scales, but are not reported in table form. There was high 
variability in the responses to the subscale questionnaire. 
Of the 34 subjects that completed the study, five female 
subjects, all who preferred the warm treatment (three with 
OA level of III and two with OA level of IV), reported a 0 of 
100 on this subscale at all measurements, and two males who 
showed preference toward either warm or contrast treatments 
(OA level II) reported a 100 out of 100 on the subscale at the 
baseline. Thus, analysis of changes was limited to 27 subjects. 
Analysis of variance within this remaining group indicated a 
nonsignificant change in the function, sport, and recreational 
activities subscale with all treatment options, (P . 0.168) 
and change scores ranging from 0 to ± 67 points.
Responses similar to the KOOS data were noted in the 
visual analog pain assessment data, where greater relief 
was obtained when subjects used their preferred treatment 
(Table 5). Relief on the pain scale is reported as a positive 
percentage of improvement. Interestingly, the pattern of simi-
larity between the KOOS pain and visual analog pain data did 
Table 2 Breakdown of treatment preferences for all subjects (n = 34)
Overall preference (N = 34)
Most preferred treatment 
(% of population)
2nd most preferred treatment 
(% of population)
3rd most preferred treatment 
(% of population)
Warm (47%) Warm (36%) Contrast (42%)
Cold (24%) Cold (26%) Cold (29%)
Contrast (24%) Contrast (21%) hot pad (18%)
hot pad (5%) hot pad (17%) Warm (11%)Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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not extend to the responses of the group that preferred the 
warm treatment. In this group, the greatest average change 
in the visual analog scale was seen following the contrast 
treatment (see Table 5). Similar to the changes in the KOOS 
subscales, the effect size estimates ranging from 0.68 to 1.12, 
was greatest when individuals used their preferred treatment 
versus all other treatment options.
Interestingly, nonsignificant differences were found 
between day 5 and day 7 reports. This nonsignificant differ-
ence (P . 0.56) was found across all treatment options for 
Table 3 Table of the group average ± standard deviation of the magnitude of change for the measures of the KOOs scale (0–100) for 
pain and symptoms from the baseline measure for the indicated treatment option on the water-circulating device for the entire group, 
and then for the subgroups of subjects based on preference
Change in KOOS  
scale after control  
treatment
Change in KOOS  
scale after cold  
treatment
Change in KOOS  
scale after contrast  
treatment
Change in KOOS  
scale after warm  
treatment
Change in KOOS   
scale after hot  
pad treatment
KOOS-pain
Average for all subjects 1.1 ± 16.6 5.6 ± 15.4a 7.0 ± 16.7a 7.0 ± 17.4a 4.2 ± 14.9
Average for prefer cold 
treatment
-6.7 ± 11.9 0.1 ± 14.6 -0.4 ± 10.6 5.9 ± 14.5a 4.7 ± 17.4
Average for prefer  
contrast treatment
-0.2 ± 10.7 1.74 ± 14.6a 8.9 ± 16.9a 6.2 ± 18.2a 2.8 ± 9.3
Average for prefer  
warm treatment
4.1 ± 19.6 6.4 ± 16.8 9.3 ± 18.9 6.8 ± 19.9 3.2 ± 16.2
KOOS-symptom
Average for all subjects 0.5 ± 14.0 6.1 ± 15.2a 7.5 ± 15.9a 6.7 ± 15.6a 5.3 ± 15.7a
Average for prefer cold 
treatment
-2.1 ± 20.4 5.8 ± 19.4a 3.4 ± 17.1a 12.1 ± 19.9a 9.6 ± 21.5a
Average for prefer  
contrast treatment
-0.4 ± 10.6 9.6 ± 12.4a 7.9 ± 11.2a 5.4 ± 12.7a 0.1 ± 11.8
Average for prefer  
warm treatment
1.3 ± 2.6 3.3 ± 15.2 9.3 ± 18.5 3.2 ± 14.7 4.6 ± 14.6
Notes: aIndicates values of change significant from change after control, T-test P , 0.05. 
Abbreviation: KOOs, knee injury and osteoarthritis outcome score. 
Table 4 Table of the group average ± standard deviation of the magnitude of change for the measures of the KOOs scale (0–100) for 
FDL and QOL from the baseline measure for the indicated treatment option on the water-circulating device for the entire group and 
then for the subgroups of subjects based on preference
Change in KOOS  
scale after control  
treatment
Change in KOOS  
scale after cold  
treatment
Change in KOOS  
scale after contrast  
treatment
Change in KOOS  
scale after warm  
treatment
Change in KOOS   
scale after hot  
pad treatment
KOOS-FDL
Average for all subjects -0.1 ± 15.5 6.1 ± 16.1a 6.6 ± 16.0a 7.2 ± 15.6a 4.2 ± 15.1a
Average for prefer  
cold treatment
-7.5 ± 17.2 3.3 ± 22.3 4.4 ± 20.6 8.7 ± 18.4 0.3 ± 17.9
Average for prefer  
contrast treatment
4.5 ± 5.8 8.2 ± 17.7b 8.0 ± 15.5 4.8 ± 15.6 -1.8 ± 17.2
Average for prefer  
warm treatment
4.1 ± 17.9 7.7 ± 15.6 8.4 ± 16.3 8.1 ± 17.2 7.4 ± 14.1
KOOS-QOL
Average for all subjects 3.3 ± 12.6 8.0 ± 14.9a 9.1 ± 14.4a 9.0 ± 16.2a 9.0 ± 14.0a
Average for prefer  
cold treatment
5.9 ± 18.8 10.1 ± 8.7a 9.9 ± 7.4a 13.9 ± 14.0a 15.9 ± 13.8a
Average for prefer  
contrast treatment
-2.0 ± 11.3 7.7 ± 16.3b 6.5 ± 14.7a,b 4.5 ± 5.2 0.9 ± 15.4
Average for prefer  
warm treatment
0.5 ± 10.7 7.3 ± 18.2 8.9 ± 17.6 8.1 ± 19.1a 8.3 ± 13.7
Notes: aIndicates values of change significant from change after control, T-test P , 0.05. bIndicates that change from preferred treatment is significantly greater than any other 
treatment option, T-test P , 0.05.
Abbreviations: KOOs, knee injury and osteoarthritis outcome score; FDL, function in daily living and recreation; QOL, quality of life. Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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all points of interest for all subjects. This finding suggests 
that changes in these measures may persist for a period of 
48 hours after 5 days of continuous intervention.
Discussion
These findings demonstrate that participants with knee OA 
have individual preferences with regard to the use of heat, 
cold, or contrast to relieve pain and foster greater motor 
function. It is also apparent that the use of a wrap-around 
garment that allows temperature-controlled water to heat 
or cool is much preferred over a standard heating pad. The 
reasons for preferences to heat, cold, or contrast require 
additional investigation, but gender, age, and severity of OA 
are all likely to play some role. Women most often preferred 
treatment providing warmth, while men were more likely to 
choose cold or contrast as their preferred choices of treat-
ment. Although more women were included in our study, the 
gender distribution was similar to that of the Bjordal et al,5 
Zhang et al,6 and Tubach et al19 reports, and reflects a gender 
difference in disease prevalence.
On the whole, all of the active treatments resulted in 
improvement in all measures of interest (see Tables 3 and 4). 
These findings must be viewed within the context of the 
research design. First, we recognize that it is not possible to 
blind patients to treatment when applying thermal modali-
ties. Moreover, the opportunity to use a novel treatment 
device may have influenced the responses provided by these 
patients. However, use of a water circulating device permit-
ted us to learn what treatments (heat, cold, or contrast) these 
patients preferred using a single application method, and to 
begin examining the relationships between preference and 
self-report of pain and function in patients with clinically 
significant knee OA.
We believe that the average magnitude of change reported 
on the KOOS and visual pain scale is sufficient to warrant 
further attention. Tubach et al19 reported that a 32% relative 
change in pain represented a minimal clinically important 
improvement and corresponded to a “fair” response in 
patients with knee and hip OA treated with nonsteroidal 
anti-inflammatory drugs (NSAIDs). When preferred treat-
ments of cold and warm were used, the patients in this sample 
reported a mean pain reduction of 33% and 23% respectively. 
It is unknown what longer-term use might yield, but some 
patients can achieve meaningful relief through these interven-
tions that persist for at least 2 days, with little risk. Responses 
also fell within the range of clinically important difference 
as reported by Roos,17 and correspond to the percent change in 
the pain (see Table 5) in individual studies of the response to 
NSAIDs4,5 and nonsurgical treatment options5 for individu-
als with knee OA. The effect size for change in pain with use 
of the preferred treatment was larger (44%–48%) than the 
nonpreferred treatment options (16%–36%) when the water-
circulating device was used. Bjordal et al5 reported the effect 
size for change in pain associated with the use of NSAIDs 
of 23% when nonresponders to medication were included in 
the analysis. We observed, especially in patients with more 
severe OA, that none of the treatments greatly changed the 
outcomes measures, however we do not believe this sample is 
sufficient for subgroup analysis of responders.
While not the primary purpose of this project, the find-
ings related to contrast treatment are quite interesting from 
a clinical perspective. When preferred, contrast treatment 
provided at least a two-fold difference to the next closest 
response to any of the other treatment options, in the percent 
change of the visual pain scale. While described in thera-
peutic modality texts,14,15 contrast treatment has not been 
Table 5 Table of the group average, ± standard deviation, percent change of improvement, (treatment measure-baseline measure)/
baseline measure, (0–1.0) for the measures on 10 cm visual pain scale from the baseline measure for the indicated treatment option on the 
water-circulating device for all subjects and the subgroups of subjects based on preferences, gender and severity of osteoarthritis pain
% Change in  
10 cm visual  
analog scale after 
control treatment
% Change in  
10 cm visual  
analog scale after  
cold treatment
% Change in  
10 cm visual  
analog scale after 
warm treatment
% Change in  
10 cm visual  
analog scale after 
contrast treatment
% Change in  
10 cm visual 
analog scale after 
hot pad treatment
Average for all subjects 0.04 ± 0.50 0.15 ± 0.25a 0.21 ± 0.24a 0.19 ± 0.26a 0.15 ± 0.25a
Average for prefer cold  
treatment
0.00 ± 0.36 0.33 ± 0.18a,b 0.22 ± 0.18a 0.19 ± 0.22a 0.20 ± 0.26a
Average for prefer  
contrast treatment
0.00 ± 0.14 0.09 ± 0.34a 0.29 ± 0.25a,b 0.11 ± 0.27a 0.08 ± 0.26a
Average for prefer  
warm treatment
-0.08 ± 0.72 0.03 ± 0.20a 0.23 ± 0.18a 0.20 ± 0.22a 0.08 ± 0.26a
Notes: aIndicates values of change significant from change after control day, T-test P , 0.05. bIndicates that change from preferred treatment is significantly greater than hot 
pad treatment option, T-test P , 0.05.Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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extensively studied, especially in patient populations. Hing 
et al13 completed a systematic review of contrast treatment 
and concluded that there is insufficient evidence to draw 
conclusions about this form of therapy. More importantly all 
of the randomized controlled clinical trials included in their 
report involved active athletes and college-aged patients, 
making generalizations to older and diseased populations 
problematic.
Moreover, the outcome measures reported were of little 
clinical interest, with the exception of measures of swelling 
following acute ankle sprain in college-aged patients.18 Thus, 
our findings may be the first report to address measures of 
contrast therapy treatment outcomes that are truly meaningful 
to patients in a non-college aged or athletic populations.
Contrast treatment provided the greatest improvement 
in two of the four KOOS subscales, and was far superior 
for improving subjects’ pain rating via a visual pain scale. 
This finding is quite surprising given that the contrast treat-
ment was not the most preferred treatment. However, some 
subjects noted that having to manually change from a warm 
setting to a cold setting at specific intervals of time as a prime 
reason for not preferring contrast. If the responses to contrast 
treatment we observed are substantiated through additional 
investigation, the use of an automatic timer to switch settings 
might change patient perception.
Despite the exploratory nature of this study, our findings 
have implications for clinicians as well as patients. Rather 
than recommending that a patient specifically use heat or 
cold, we suggest that patients be advised to experiment 
with heat, cold, and if possible contrast, to identify their 
individual preference for treatment, and/or under which 
condition(s) they experience the greatest relief of pain or 
symptoms. It is also possible that patients may find that 
their preference changes under differing circumstances. 
Several subjects noted that their symptoms fluctuated with 
variations in activity, and in some cases, the weather. Once 
again, individual experimentation may yield greater relief 
under specific circumstances in a safe and relatively cost-
effective manner.
Conclusion
In summary, we observed distinctly individual preferences 
for the use of heat, cold and contrast in patients with knee 
OA. A preference for treatment with a wrap-around garment 
over the use of a standard heating pad was also observed. 
In general, greater pain relief and functional improvements 
were found when subjects used their treatment of preference. 
These data support the recommendation that superficial heat 
or cold be included in the early efforts to manage patients 
with knee OA, and demonstrate that contrast be consid-
ered as a treatment option. We acknowledge that this is a 
preliminary investigation into the preferences of patients 
with knee OA to treatments. Heat and cold applications are 
noninvasive, generally safe, and low cost treatments. It is 
recommended that future avenues of research include the 
use of clinical assessments of functionality, eg, the 6-min-
ute walk test, stand-and-walk test, or step test, along with a 
longer period of treatment to assess both the role of prefer-
ence for self-directed, in-home care, and possible functional 
outcomes for patients. It is, we believe, apparent that patient 
preference must be considered in the development of future 
investigations.
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